C84.63

Clinical Causes: Genetic alterations leading to abnormal ALK gene activation Chromosomal translocations involving the ALK gene, often seen in cancer cells Possible environmental factors, although specific causes are not well-established

Key Symptoms: Swelling or painless lump in the abdominal area Abdominal pain or discomfort Unexplained weight loss Fever and night sweats Fatigue or feeling of weakness Bloating or a sensation of fullness in the abdomen Nausea or vomiting in some cases

Diagnosis Path: Diagnosing anaplastic large cell lymphoma, ALK-positive, involves a combination of medical examinations and tests, including: - Physical examination to identify swollen lymph nodes - Imaging studies such as CT scans or PET scans to locate affected areas - Biopsy of the affected lymph nodes to analyze cellular features - Laboratory tests to detect the presence of ALK protein expression in cancer cells - Blood tests to assess overall health and organ function Confirmation typically requires microscopic examination of tissue samples and specialized tests for ALK protein detection, ensuring an accurate diagnosis.

Treatment Protocols: Treatment options for ALK-positive anaplastic large cell lymphoma typically include chemotherapy, targeted therapy, and sometimes radiation therapy. Approaches may involve: - Chemotherapy regimens tailored to lymphoma, aimed at destroying cancer cells - Targeted therapies that specifically inhibit the ALK protein, such as ALK inhibitors, which can be effective in cases where the cancer expresses this protein - Supportive care to manage symptoms and maintain overall health during treatment - In some cases, stem cell transplantation might be considered, especially if the disease shows resistance to initial therapies The choice of treatment depends on the stage of the disease, the patient’s overall health, and specific characteristics of the cancer.